Correlation Between Co Diagnostics and Tempest Therapeutics

Can any of the company-specific risk be diversified away by investing in both Co Diagnostics and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Co Diagnostics and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Co Diagnostics and Tempest Therapeutics, you can compare the effects of market volatilities on Co Diagnostics and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Co Diagnostics with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Co Diagnostics and Tempest Therapeutics.

Diversification Opportunities for Co Diagnostics and Tempest Therapeutics

-0.03

Correlation Coefficient

Co Diagnostics  Tempest Therapeutics

Good diversification

The 3 months correlation between CODX and Tempest is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Co Diagnostics and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Co Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Co Diagnostics are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Co Diagnostics i.e., Co Diagnostics and Tempest Therapeutics go up and down completely randomly.

Pair Corralation between Co Diagnostics and Tempest Therapeutics

Given the investment horizon of 90 days Co Diagnostics is expected to under-perform the Tempest Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Co Diagnostics is 1.11 times less risky than Tempest Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Tempest Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  655.00  in Tempest Therapeutics on May 14, 2025 and sell it today you would earn a total of  226.00  from holding Tempest Therapeutics or generate 34.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Co Diagnostics  vs.  Tempest Therapeutics

Co Diagnostics

Risk-Adjusted Performance

Weakest

Over the last 90 days Co Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Tempest Therapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Tempest Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tempest Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Co Diagnostics and Tempest Therapeutics

The main advantage of trading using opposite Co Diagnostics and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Co Diagnostics position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.

The idea behind Co Diagnostics and Tempest Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.